Novartis on 4 Ways It Is Pursuing the Challenge of Treating Lung Cancer

Originally published on LinkedIn. Novartis Pharmaceuticals is a DiversityInc Hall of Fame company.

 

Lung cancer is the number one cause of death from cancer worldwide. Novartis Pharmaceuticals is currently pursuing the challenge on four fronts.

To learn more about Novartis’ advancements in helping to treat lung cancer, click here.

Latest News

5 Biggest News Stories of the Week: May 26

As the saying goes, the news never stops — but there’s a lot of it out there, and all of it doesn’t always pertain to our readers. In this weekly news roundup, we’ll cover the top news stories that matter most to our diversity focused audience. 1. More Than 200…

Tips from KeyBank on Improving Mental Health in the Workplace

With May being Mental Health Awareness Month, many companies are looking into how to support employees’ mental health and wellbeing in and out of the workplace.  For KeyBank (ranked No. 18 on the 2022 DiversityInc Top 50 Companies for Diversity list), the company listens to its employees and attempts to understand…